Skip to content
The Policy VaultThe Policy Vault

CaystonUnited Healthcare

cystic fibrosis with Pseudomonas aeruginosa lung infection

Initial criteria

  • Diagnosis of cystic fibrosis (CF)
  • Lung infection with positive culture demonstrating Pseudomonas aeruginosa infection

Reauthorization criteria

  • Documentation of positive clinical response to Cayston therapy

Approval duration

12 months